12 research outputs found
Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
No full textA phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
No full text
L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice
No full textTargeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
No full textCombination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
No full textIdentification of unique neoantigen qualities in long-term survivors of pancreatic cancer
No full text
